Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription termination factor 2 (TTF2) is a member of the SWI2/SNF2 family and encodes a dsDNA-dependent ATPase that functions as a transcription termination factor by coupling ATP hydrolysis with the active removal of RNA polymerase II from the DNA template[1][2][6]. TTF2 interacts with proteins such as cell division cycle 5-like and is involved in pre-mRNA splicing, chromatin remodeling, and mitotic transcription repression[1][2][3][4][6]. TTF2 is essential for proper control of gene expression during development and cell cycle progression, and its genetic locus is on human chromosome 1[1][4]. No direct associations with therapeutically targeted diseases or drugs have been documented in the current sources, and no established biomarkers or safety concerns are reported as of now.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription termination factor 2 (TTF2).